Intelligent Medicine Volume 2 Issue 1 to 4

“Intelligent Medicine” is an open-access, peer-reviewed journal that focuses on the intersection of medical-industrial crossover and technology. It is sponsored and owned by the Chinese Medical Association and aims to publish high-quality research and applications related to internet technology, artificial intelligence (AI), data science, medical information, and intelligent devices in the fields of clinical medicine, biomedicine, and public health. Here are some key details about the journal:

1. Ownership and Sponsorship: “Intelligent Medicine” is sponsored and owned by the Chinese Medical Association, highlighting its connection to the medical community in China.
2. Scope: The journal covers a wide range of topics at the intersection of medicine and technology, including AI, data science, medical information, and intelligent devices. It focuses on how these technologies are applied in clinical medicine, biomedicine, and public health.
3. Article Types: The journal accepts various types of articles, including:
   • Research Articles: These should be original, innovative, and significant, encompassing both medical and algorithmic research. Clinical assessment of the usefulness and reliability of medical research is encouraged.
   • Editorial: Authored by the Editor-in-Chief, Associate Editors, editorial board members, or invited experts on a broad range of topics related to science and policy.
   • Review: In-depth reviews of recent progress in specific scientific areas, including historical context, recent advances, and future perspectives.
   • Perspective & Comments: Personal opinions, hypotheses, or discussions of controversial issues are welcome.
   • Research Highlight: Summaries and comments on recent research achievements, particularly highlighting the contributions of Chinese scientists.
   • Guideline & Standard: Official recommendations from professional organizations on clinical practice, healthcare delivery, and data management in intelligent medicine.
   • Ethical, Legal, and Social Implications: Explorations of ethical issues related to intelligent medicine.
   • Case Report: Detailed case descriptions, typically limited to 1000 words, without an abstract or keywords. Patient consent must be declared if patient information is included.
   • Historical Moment: Descriptions of specific aspects, life, and stories related to historical scientific contributions and applications.
   • Letter: Letters to the editors, preferably related to previously published articles in the journal.
4. Word Limits: Articles have varying word limits depending on their type, ranging from 500 words for letters to 6,000 words for research articles and reviews.
5. Structured Abstract: Research articles include a structured abstract with sections for Background, Methods, Results, and Conclusion.
6. Patient Consent: Patient consent is required for case reports and should be stated in the paper.

“Intelligent Medicine” appears to provide a platform for researchers and experts to share their insights, findings, and perspectives on the rapidly evolving field of intelligent medicine, with a particular emphasis on the application of technology and data science in healthcare.

Volume 2, Issue 1: Pages 1-60 (February 2022)

Volume 2, Issue 2: Pages 61-116 (May 2022)

Volume 2, Issue 3: Pages 117-180 (August 2022)

Volume 2, Issue 4: Pages 181-240 (November 2022)